More than 99 percent of these microbes had never been studied before. Each coral species carried its own special team of microbes, which means the partnership between coral and microbe is not random — it has been shaped over millions of years.
Some of these microbes make compounds that could be useful as medicines. In one test, a chemical from a coral microbe blocked an enzyme linked to inflammation. Scientists warn that if reefs die, we could lose a hidden library of future drugs.
Coral reefs occupy less than one percent of the ocean floor, yet they shelter roughly a quarter of all known marine species. Now a study published this month suggests that the diversity of life on the reef is even greater than scientists had imagined — most of it microscopic and hidden inside the corals themselves.
An international team led by researchers from the Pacific Ocean basin sampled 99 coral reefs spread across 32 islands. From those samples, they reconstructed the genomes of 645 distinct microbial species, more than 99 percent of which had never been described before. Each coral species carried a strikingly specific microbiome, suggesting a tight evolutionary partnership rather than chance colonisation.
The findings matter because many of those microbes are biochemical factories. The team identified an unusually wide range of biosynthetic gene clusters — stretches of DNA that contain instructions for making complex natural compounds. In one experiment, a compound produced by a coral-associated bacterium inhibited human neutrophil elastase, an enzyme involved in chronic inflammatory diseases, at low doses.
Researchers stress that this microscopic library is fragile. Coral reefs are already under severe pressure from warming seas, ocean acidification and pollution. Losing reefs would not only erase a vast share of marine biodiversity; it would also close off a still-largely-unexplored source of compounds that could one day yield new antibiotics, anti-inflammatories and cancer drugs.
A study published this month has dramatically expanded our census of life on coral reefs by looking, for the first time at scale, at the microbial communities living inside the coral animals themselves. An international team sampled 99 reefs spread across 32 islands of the Pacific basin and, using metagenomic sequencing, reconstructed the genomes of 645 distinct microbial species. More than 99 percent of those genomes belong to organisms that had never been formally described in the scientific literature.
The most striking pattern is host specificity. Each coral species carries a tightly tailored consortium of microbial partners that other coral species, even on the same reef, do not host. That degree of specialisation is hard to reconcile with chance colonisation; it implies a long history of co-evolution in which the coral and its microbes have shaped each other's biology, much as the gut microbiome and its mammalian host do on land.
Pharmacologically, the data are tantalising. The team flagged an exceptionally rich repertoire of biosynthetic gene clusters, the genomic apparatus that bacteria use to manufacture complex natural products. Many of those clusters appear novel, and an early functional assay showed that a compound from one coral-associated bacterium inhibits human neutrophil elastase — a serine protease implicated in chronic inflammatory conditions including emphysema, cystic fibrosis and acute respiratory distress syndrome — at low micromolar concentrations, the kind of potency that pharmaceutical chemists treat as a viable starting point for drug development.
The strategic implication is sobering. Reef ecosystems already face a triad of existential pressures: thermal stress from a warming ocean, acidification from rising atmospheric carbon dioxide, and chronic terrestrial runoff. Losing them would carry an obvious ecological cost, but the new work makes the case that it would also amputate a still largely unexplored source of pharmacological diversity. Scientists who once spoke of reefs as nurseries of fish increasingly speak of them as nurseries of molecules — and the second framing may be the one that finally turns conservation into an economic priority.
An international team has reconstructed the genomes of 645 microbial species living inside Pacific corals, more than 99 percent of them never described before. Each coral host carries its own specialised partners, and many of these microbes produce chemical compounds that could become future drugs.
Coral reefs are like cities under the sea. Many fish and other animals live there.
Scientists found something new. There are very tiny living things inside the corals. These are called microbes. You cannot see them with your eyes.
The team looked at corals on 99 reefs in the Pacific Ocean. They found 645 kinds of microbes. Almost all of them were new to science.
Some of these microbes make special chemicals. These chemicals could one day help to make new medicines for people.
1What did scientists find in the corals?
2How many reefs did they look at?
3How many kinds of microbes did they find?
4Why are the chemicals important?
5Where are the reefs?
6Microbes are very small.
7All the microbes were already known.
8Coral reefs are like cities under the sea.
9The chemicals could help make medicines.
10The team only checked one reef.
11The very small living things are called ___.
12The team studied ___ reefs.
13They found ___ kinds of microbes.